(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.86%) $83.13
(-1.16%) $1.619
(-0.47%) $2 336.20
(0.84%) $27.48
(0.48%) $926.50
(-0.20%) $0.933
(-0.16%) $11.01
(-0.26%) $0.798
(0.00%) $92.17
Live Chart Being Loaded With Signals
Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 2,000 diagnostic test services, including immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology...
Stats | |
---|---|
Šios dienos apimtis | 67 708.00 |
Vidutinė apimtis | 330 740 |
Rinkos kapitalizacija | 189.30M |
EPS | $0 ( 2023-11-20 ) |
Kita pelno data | ( $0 ) 2024-05-29 |
Last Dividend | $0.0490 ( 2021-07-08 ) |
Next Dividend | $0 ( N/A ) |
P/E | 15.78 |
ATR14 | $0 (0.00%) |
Integrated Diagnostics Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Integrated Diagnostics Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $4.12B |
Bruto pelnas: | $1.52B (36.98 %) |
EPS: | $0.850 |
FY | 2023 |
Pajamos: | $4.12B |
Bruto pelnas: | $1.52B (36.98 %) |
EPS: | $0.850 |
FY | 2022 |
Pajamos: | $3.61B |
Bruto pelnas: | $1.46B (40.56 %) |
EPS: | $0.900 |
FY | 2021 |
Pajamos: | $5.22B |
Bruto pelnas: | $2.80B (53.67 %) |
EPS: | $2.35 |
Financial Reports:
No articles found.
Integrated Diagnostics Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.0150 | 2016-04-07 |
Last Dividend | $0.0490 | 2021-07-08 |
Next Dividend | $0 | N/A |
Payout Date | 2021-07-29 | |
Next Payout Date | N/A | |
# dividends | 6 | -- |
Total Paid Out | $0.230 | -- |
Avg. Dividend % Per Year | 0.90% | -- |
Score | 3.44 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.25 | |
Div. Directional Score | 8.39 | -- |
Year | Amount | Yield |
---|---|---|
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0.0400 | 3.34% |
2019 | $0.0440 | 4.18% |
2020 | $0.0468 | 4.65% |
2021 | $0.0490 | 4.45% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
STS.L | Dividend King | 2023-10-05 | Quarterly | 38 | 1.48% | |
JUST.L | Dividend Royal | 2023-08-24 | Annually | 11 | 93.97% | |
CCEP.L | Dividend Knight | 2023-05-11 | Annually | 6 | 1.61% | |
QQ.L | Dividend Knight | 2023-07-27 | Semi-Annually | 19 | 1.52% | |
GFTU.L | Dividend Knight | 2023-09-21 | Semi-Annually | 15 | 2.21% | |
ALFA.L | Dividend King | 2023-09-14 | Semi-Annually | 5 | 3.78% | |
TORO.L | Dividend King | 2023-08-10 | Quarterly | 9 | 8.28% | |
LWI.L | Dividend King | 2023-06-29 | Quarterly | 53 | 2.58% | |
CRDA.L | Dividend Knight | 2023-08-31 | Semi-Annually | 32 | 0.95% | |
RTC.L | Dividend Royal | 2023-08-03 | Annually | 27 | 157.11% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.124 | 1.500 | 7.52 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0884 | 1.200 | 7.05 | 8.46 | [0 - 0.3] |
returnOnEquityTTM | 0.201 | 1.500 | 8.88 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.539 | 0.800 | 7.31 | 5.85 | [1 - 3] |
quickRatioTTM | 1.103 | 0.800 | 8.22 | 6.57 | [0.8 - 2.5] |
cashRatioTTM | 0.529 | 1.500 | 8.17 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.174 | -1.500 | 7.10 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 12.76 | 1.000 | 6.38 | 6.38 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.906 | 2.00 | 9.70 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.365 | 2.00 | 9.82 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.374 | -1.500 | 8.50 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.370 | 1.000 | 7.17 | 7.17 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.218 | 1.000 | 7.64 | 7.64 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.542 | 1.000 | 8.10 | 8.10 | [0.2 - 2] |
assetTurnoverTTM | 0.714 | 0.800 | 8.57 | 6.86 | [0.5 - 2] |
Total Score | 12.52 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 17.75 | 1.000 | 8.31 | 0 | [1 - 100] |
returnOnEquityTTM | 0.201 | 2.50 | 9.28 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.365 | 2.00 | 9.88 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.906 | 2.00 | 9.70 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.00309 | 1.500 | -3.31 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.132 | 1.000 | 9.20 | 0 | [0.1 - 0.5] |
Total Score | 4.25 |
Integrated Diagnostics
Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 2,000 diagnostic test services, including immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. The company operates in Egypt, Jordan, Sudan, and Nigeria. As of December 30, 2021, it operated a network of 452 branch labs. The company was founded in 1979 and is headquartered in Saint Helier, Jersey.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.